Facioscapulohumeral Atrophy

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Facioscapulohumeral Atrophy?

There are 1 clinical trial targeting Facioscapulohumeral Atrophy tracked by BioSniper.

What is the prevalence of Facioscapulohumeral Atrophy?

The estimated prevalence of Facioscapulohumeral Atrophy is approximately 30.0 per 100,000 population.

Deep-dive into Facioscapulohumeral Atrophy

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Facioscapulohumeral Atrophy — Drugs in Development & Clinical Trials | BioSniper